September 1, 1999Current Opinion in Nephrology & Hypertension
Endothelin antagonists for hypertension and renal disease
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Should not change practice yet; leaves open therapeutic potential pending larger randomized trials.
Structured PICO
I
Intervention
Endothelin antagonists
Endothelin antagonists show therapeutic potential for reducing end-organ damage in hypertension and renal disease based on experimental and early clinical evidence.
Cite This Study
Barton et al. (1999) studied this question.